EU may have 'relied a little bit too much on the free markets' for vaccines, top scientist says

The United States and the United Kingdom are outpacing the European Union when it comes to vaccinating citizens against COVID-19. The main reason why that's the case, The New York Times reports, appears to go all the way back to last year.
Early on, the U.S. and U.K. governments threw a lot more money at, and were much more involved in, vaccine development than the EU, which "shopped for vaccines like a customer," the Times writes. Brussels "assumed that simply contracting to acquire doses would be enough," Dr. Moncef Slaoui, who was hired by former President Donald Trump to oversee Operation Warp Speed's vaccine development, told the Times. "In fact," he added, "what was very important was to be a full, active partner in the development and manufacturing of the vaccine. And to do so very early."
Dr. Steven Van Gucht, the Belgium government's top virologist, seemed to agree, telling the Times he thinks European leaders "relied a little bit too much on the free markets. What you really need to do from the beginning is really make sure you produce the vaccines on your territory and that they're destined for your own population."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There is good news, though. The EU purchased enough doses to fully vaccinate its population three times over, and supply is expected to increase steadily in the next few weeks, leaving EU officials confident the bloc can hit the 70 percent vaccinated threshold by this summer. Read more at The New York Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Amazon's 'James Bond' deal could mean a new future for 007
In the Spotlight The franchise was previously owned by the Broccoli family
By Justin Klawans, The Week US Published
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
What is JD Vance's Net Worth?
In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published